Found: 10
Select item for more details and to access through your institution.
Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 9, p. 2565, doi. 10.1007/s00520-013-1804-9
- By:
- Publication type:
- Article
Patients' experiences with cancer care in Switzerland: Results of a multicentre cross‐sectional survey.
- Published in:
- European Journal of Cancer Care, 2022, v. 31, n. 6, p. 1, doi. 10.1111/ecc.13705
- By:
- Publication type:
- Article
Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
- Published in:
- Oncology, 2018, v. 95, n. 2, p. 61, doi. 10.1159/000489217
- By:
- Publication type:
- Article
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pemetrexed-associated radiation recall dermatitis.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 8, p. 1607, doi. 10.1080/02841860802120036
- By:
- Publication type:
- Article
Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143522
- By:
- Publication type:
- Article
Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Quel est votre diagnostic?
- Published in:
- Praxis (16618157), 2008, v. 97, p. 883, doi. 10.1024/1661-8157.97.16.883
- By:
- Publication type:
- Article
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2- negative advanced stage breast cancer - a multicenter, randomized phase III trial
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2823-y
- By:
- Publication type:
- Article